Plasmin-mediated Cleavage of High Molecular Weight Kininogen Contributes to Acetaminophen-Induced Acute Liver Failure

Standard

Plasmin-mediated Cleavage of High Molecular Weight Kininogen Contributes to Acetaminophen-Induced Acute Liver Failure. / Henderson, Michael W; Sparkenbaugh, Erica M; Wang, Shaobin; Ilich, Anton; Noubouossie, Denis F; Mailer, Reiner K; Renné, Thomas; Flick, Matthew J; Luyendyk, James P; Chen, Zu-Lin; Strickland, Sidney; Stravitz, R Todd; McCrae, Keith R; Key, Nigel S; Pawlinski, Rafal.

In: BLOOD, Vol. 138, No. 3, 22.07.2021, p. 259-272.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Henderson, MW, Sparkenbaugh, EM, Wang, S, Ilich, A, Noubouossie, DF, Mailer, RK, Renné, T, Flick, MJ, Luyendyk, JP, Chen, Z-L, Strickland, S, Stravitz, RT, McCrae, KR, Key, NS & Pawlinski, R 2021, 'Plasmin-mediated Cleavage of High Molecular Weight Kininogen Contributes to Acetaminophen-Induced Acute Liver Failure', BLOOD, vol. 138, no. 3, pp. 259-272. https://doi.org/10.1182/blood.2020006198

APA

Henderson, M. W., Sparkenbaugh, E. M., Wang, S., Ilich, A., Noubouossie, D. F., Mailer, R. K., Renné, T., Flick, M. J., Luyendyk, J. P., Chen, Z-L., Strickland, S., Stravitz, R. T., McCrae, K. R., Key, N. S., & Pawlinski, R. (2021). Plasmin-mediated Cleavage of High Molecular Weight Kininogen Contributes to Acetaminophen-Induced Acute Liver Failure. BLOOD, 138(3), 259-272. https://doi.org/10.1182/blood.2020006198

Vancouver

Bibtex

@article{21fa82bd547b4aa98144e1228d00d389,
title = "Plasmin-mediated Cleavage of High Molecular Weight Kininogen Contributes to Acetaminophen-Induced Acute Liver Failure",
abstract = "Acetaminophen (APAP)-induced liver injury is associated with activation of coagulation and fibrinolysis. In mice, both tissue factor-dependent thrombin generation and plasmin activity have been shown to promote liver injury after APAP overdose. However, the contribution of the contact and intrinsic coagulation pathways has not been investigated in this model. Mice deficient in individual factors of the contact (factor XII [FXII] and prekallikrein) or intrinsic coagulation (FXI) pathway were administered a hepatotoxic dose of 400 mg/kg of APAP. Neither FXII, FXI, nor prekallikrein deficiency mitigated coagulation activation or hepatocellular injury. Interestingly, despite the lack of significant changes to APAP-induced coagulation activation, markers of liver injury and inflammation were significantly reduced in APAP-challenged high-molecular-weight kininogen-deficient (HK-/-) mice. Protective effects of HK deficiency were not reproduced by inhibition of bradykinin-mediated signaling, whereas reconstitution of circulating levels of HK in HK-/- mice restored hepatotoxicity. Fibrinolysis activation was observed in mice after APAP administration. Western blotting, enzyme-linked immunosorbent assay, and mass spectrometry analysis showed that plasmin efficiently cleaves HK into multiple fragments in buffer or plasma. Importantly, plasminogen deficiency attenuated APAP-induced liver injury and prevented HK cleavage in the injured liver. Finally, enhanced plasmin generation and HK cleavage, in the absence of contact pathway activation, were observed in plasma of patients with acute liver failure due to APAP overdose. In summary, extrinsic but not intrinsic pathway activation drives the thromboinflammatory pathology associated with APAP-induced liver injury in mice. Furthermore, plasmin-mediated cleavage of HK contributes to hepatotoxicity in APAP-challenged mice independently of thrombin generation or bradykinin signaling.",
author = "Henderson, {Michael W} and Sparkenbaugh, {Erica M} and Shaobin Wang and Anton Ilich and Noubouossie, {Denis F} and Mailer, {Reiner K} and Thomas Renn{\'e} and Flick, {Matthew J} and Luyendyk, {James P} and Zu-Lin Chen and Sidney Strickland and Stravitz, {R Todd} and McCrae, {Keith R} and Key, {Nigel S} and Rafal Pawlinski",
note = "Copyright {\textcopyright} 2021 American Society of Hematology.",
year = "2021",
month = jul,
day = "22",
doi = "10.1182/blood.2020006198",
language = "English",
volume = "138",
pages = "259--272",
journal = "BLOOD",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "3",

}

RIS

TY - JOUR

T1 - Plasmin-mediated Cleavage of High Molecular Weight Kininogen Contributes to Acetaminophen-Induced Acute Liver Failure

AU - Henderson, Michael W

AU - Sparkenbaugh, Erica M

AU - Wang, Shaobin

AU - Ilich, Anton

AU - Noubouossie, Denis F

AU - Mailer, Reiner K

AU - Renné, Thomas

AU - Flick, Matthew J

AU - Luyendyk, James P

AU - Chen, Zu-Lin

AU - Strickland, Sidney

AU - Stravitz, R Todd

AU - McCrae, Keith R

AU - Key, Nigel S

AU - Pawlinski, Rafal

N1 - Copyright © 2021 American Society of Hematology.

PY - 2021/7/22

Y1 - 2021/7/22

N2 - Acetaminophen (APAP)-induced liver injury is associated with activation of coagulation and fibrinolysis. In mice, both tissue factor-dependent thrombin generation and plasmin activity have been shown to promote liver injury after APAP overdose. However, the contribution of the contact and intrinsic coagulation pathways has not been investigated in this model. Mice deficient in individual factors of the contact (factor XII [FXII] and prekallikrein) or intrinsic coagulation (FXI) pathway were administered a hepatotoxic dose of 400 mg/kg of APAP. Neither FXII, FXI, nor prekallikrein deficiency mitigated coagulation activation or hepatocellular injury. Interestingly, despite the lack of significant changes to APAP-induced coagulation activation, markers of liver injury and inflammation were significantly reduced in APAP-challenged high-molecular-weight kininogen-deficient (HK-/-) mice. Protective effects of HK deficiency were not reproduced by inhibition of bradykinin-mediated signaling, whereas reconstitution of circulating levels of HK in HK-/- mice restored hepatotoxicity. Fibrinolysis activation was observed in mice after APAP administration. Western blotting, enzyme-linked immunosorbent assay, and mass spectrometry analysis showed that plasmin efficiently cleaves HK into multiple fragments in buffer or plasma. Importantly, plasminogen deficiency attenuated APAP-induced liver injury and prevented HK cleavage in the injured liver. Finally, enhanced plasmin generation and HK cleavage, in the absence of contact pathway activation, were observed in plasma of patients with acute liver failure due to APAP overdose. In summary, extrinsic but not intrinsic pathway activation drives the thromboinflammatory pathology associated with APAP-induced liver injury in mice. Furthermore, plasmin-mediated cleavage of HK contributes to hepatotoxicity in APAP-challenged mice independently of thrombin generation or bradykinin signaling.

AB - Acetaminophen (APAP)-induced liver injury is associated with activation of coagulation and fibrinolysis. In mice, both tissue factor-dependent thrombin generation and plasmin activity have been shown to promote liver injury after APAP overdose. However, the contribution of the contact and intrinsic coagulation pathways has not been investigated in this model. Mice deficient in individual factors of the contact (factor XII [FXII] and prekallikrein) or intrinsic coagulation (FXI) pathway were administered a hepatotoxic dose of 400 mg/kg of APAP. Neither FXII, FXI, nor prekallikrein deficiency mitigated coagulation activation or hepatocellular injury. Interestingly, despite the lack of significant changes to APAP-induced coagulation activation, markers of liver injury and inflammation were significantly reduced in APAP-challenged high-molecular-weight kininogen-deficient (HK-/-) mice. Protective effects of HK deficiency were not reproduced by inhibition of bradykinin-mediated signaling, whereas reconstitution of circulating levels of HK in HK-/- mice restored hepatotoxicity. Fibrinolysis activation was observed in mice after APAP administration. Western blotting, enzyme-linked immunosorbent assay, and mass spectrometry analysis showed that plasmin efficiently cleaves HK into multiple fragments in buffer or plasma. Importantly, plasminogen deficiency attenuated APAP-induced liver injury and prevented HK cleavage in the injured liver. Finally, enhanced plasmin generation and HK cleavage, in the absence of contact pathway activation, were observed in plasma of patients with acute liver failure due to APAP overdose. In summary, extrinsic but not intrinsic pathway activation drives the thromboinflammatory pathology associated with APAP-induced liver injury in mice. Furthermore, plasmin-mediated cleavage of HK contributes to hepatotoxicity in APAP-challenged mice independently of thrombin generation or bradykinin signaling.

U2 - 10.1182/blood.2020006198

DO - 10.1182/blood.2020006198

M3 - SCORING: Journal article

C2 - 33827130

VL - 138

SP - 259

EP - 272

JO - BLOOD

JF - BLOOD

SN - 0006-4971

IS - 3

ER -